Trial Profile
Safety and Pharmacokinetic Evaluation of Sodium Nitrite Injection for the Prevention of Post-Subarachnoid Hemorrhage Induced Vasospasm
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 May 2020
Price :
$35
*
At a glance
- Drugs Sodium nitrite (Primary)
- Indications Subarachnoid haemorrhage; Vasospasm
- Focus Pharmacokinetics
- Sponsors Hope Pharmaceuticals
- 22 Aug 2016 New trial record